Conduit Pharmaceuticals Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
CDT, CDTTW on Nasdaq
Location
4851 Tamiami Trail North, Suite 200, Naples, FL

Insiders trading volume in the past year

Conduit Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jack Heilbron Former CEO,director&10% owner $9.19M Sep 22, 2023
Nirland Ltd 10%+ Owner $626K -$691K -52.5% Oct 3, 2024
James Bligh Interim CFO, Director $183K Nov 18, 2024
Freda Lewis-Hall Director $118K Dec 18, 2024
David Tapolczay Chief Executive Officer, Director $77.2K Nov 18, 2024
Andrew Regan Director, 10%+ Owner $63.1K -$4.59M -98.6% Jun 14, 2024
Chele Chiavacci Farley Director $62.1K Dec 18, 2024
Faith L. Charles Director $61.2K Dec 18, 2024
Simon Jeremy Fry Director $48.2K Dec 18, 2024
Jennifer Isacoff McNealey Director $0 May 13, 2024
Adam Sragovicz Chief Financial Officer May 15, 2024
Richard E. Feinberg Director Feb 2, 2022
Edwin Bentzen Chief Accounting Officer Feb 2, 2022
Francis Knuettel II Director Feb 2, 2022
Shaolin Capital Management LLC 10%+ Owner Feb 3, 2023
Murphy Canyon Acquisition Sponsor, LLC 10%+ Owner Feb 2, 2022

Recent Insider Transactions by Companies or Individuals for Conduit Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.